FKC288 in Participants With Autoimmune Kidney Diseases
Condition(s):Lupus Nephritis; ANCA-associated Vasculitis; Membranous Nephropathy – PLA2R Induced; IgG4-Related DiseasesLast Updated:March 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Lupus Nephritis; ANCA-associated Vasculitis; Membranous Nephropathy – PLA2R Induced; IgG4-Related DiseasesLast Updated:March 5, 2024Recruiting
Condition(s):Alport SyndromeLast Updated:January 30, 2024Recruiting
Condition(s):Prostatectomy; Prostate NeoplasmLast Updated:August 31, 2023Completed
Condition(s):Light Chain AmyloidosisLast Updated:November 15, 2023Recruiting
Condition(s):Lupus Nephritis; Remission; Safety IssuesLast Updated:May 18, 2023Recruiting
Condition(s):Bowel DysfunctionLast Updated:August 11, 2020Unknown status
Condition(s):AL Amyloidosis; Plasma Cell DyscrasiaLast Updated:February 26, 2024Enrolling by invitation
Condition(s):Vitamin D Deficiency; Crohn DiseaseLast Updated:October 21, 2019Unknown status
Condition(s):Lupus NephritisLast Updated:February 4, 2019Completed
Condition(s):Acute Pancreatitis; Organ Failure, MultipleLast Updated:November 27, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.